Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:
“And the plot thickens for short-course RT in rectal cancer!
72% cCR and 57% 2-year TME free survival via 4 cycles FOLFOX/CAPOX –> 25-30Gy/5 fraction RT (short course with optional boost).
Congrats Hyun Kim and looking forward to study details.”
Title: Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial
Journal: International Journal of Radiation Oncology, Biology, Physics
Authors: H. Kim, C.J. Anker, J.R. Olsen, C.L. Hallemeier, M. Silviera, J. Moore, M.M. Barry, Z. Jin, K.L. Mathis, D. Shonebarger, J. Hamner, A. Tin, H. Calkins, Y. Xu, E. Lu, M. Mutch, A. Mo, D. Denardo, K. Pedersen, S. Hunt
More from Nina Niu Sanford on OncoDaily.